Related Experiment Video
Updated: May 24, 2026

In Vitro Differentiation of Human Pluripotent Stem Cells into Trophoblastic Cells
Published on: March 16, 2017
Human first-trimester chorionic villi have a myogenic potential.
Reiko Arakawa1, Ryoko Aoki, Masayuki Arakawa
1Affiliated Field of Medical Genetics, Division of Biomedical Engineering and Science, Graduate Course of Medicine, Graduate School of Tokyo Women's Medical University, Tokyo, Japan.
First-trimester chorionic-villi-derived cells (FTCVs) show promise for Duchenne muscular dystrophy (DMD) cell therapy. These early fetal cells can differentiate into skeletal muscle cells expressing dystrophin, offering a potential new treatment for DMD.
Area of Science:
- Regenerative Medicine
- Developmental Biology
- Genetics
Background:
- Duchenne muscular dystrophy (DMD) is a severe X-linked disorder with limited treatment options.
- Cell therapy presents a promising avenue for treating muscle degeneration in DMD patients.
- First-trimester chorionic-villi-derived cells (FTCVs) represent the earliest available fetal material for diagnostic and therapeutic applications.
Purpose of the Study:
- To investigate the potential of FTCVs as a source for cell therapy in DMD.
- To assess the expression of stem cell markers and the myogenic differentiation capacity of FTCVs.
- To determine if FTCVs can differentiate into skeletal muscle cells expressing dystrophin.
Main Methods:
- FTCVs were analyzed for mesenchymal stem cell and pluripotent stem cell markers (Nanog, Sox2).
- Myogenic induction was performed on FTCVs to assess their differentiation potential.
- Gene and protein expression (MyoD, myogenin, desmin, dystrophin) was evaluated during myogenic differentiation.
Main Results:
- FTCVs expressed mesenchymal stem cell markers and pluripotent markers Nanog and Sox2.
- Upon myogenic induction, FTCVs differentiated into myotubes, with down-regulation of Nanog/Sox2 and up-regulation of myogenic markers.
- Successfully differentiated cells expressed dystrophin, a key marker for skeletal muscle development.
Conclusions:
- FTCVs possess significant myogenic potential, differentiating into skeletal muscle cells expressing dystrophin.
- This study demonstrates for the first time the efficient in vitro differentiation of FTCVs into dystrophin-expressing skeletal muscle cells.
- FTCVs are a promising candidate cell source for developing novel cell therapies for Duchenne muscular dystrophy.
More Related Videos
Related Concept Videos
Development of Blood Vessels
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
Development of the Sexual Organs in the Embryo and Fetus
Near the gonadal ridges, two duct systems are present: the mesonephric ducts (Wolffian ducts) and paramesonephric ducts (Müllerian ducts). These ducts form the basis for the male...
Formation of Muscle Fibers from Myoblasts
Muscle progenitor cells (MPCs) are formed from the myotomes. MPCs express genes that encode the transcription factors Pax3 and Pax7. Along with Pax 3/7, other transcription factors...

